Prokineticin‐2 Is Highly Expressed in Colonic Mucosa of Early Parkinson's Disease Patients
Movement Disorders · 2024
DOI: 10.1002/mds.29937 ↗Kurz gefasst
Fachartikel in der Zeitschrift Movement Disorders, 2024. Verfasst von Gabriele Bellini und 12 weiteren Autor:innen. Beteiligte Einrichtung: Neurology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. Hauptthemen laut MEDLINE: Parkinson Disease, Intestinal Mucosa, Colon. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 31 Literaturangaben.
Abstract (Originalsprache)
Background
Elevated levels of prokineticin‐2 (PK2), regarded as a protein involved in modulating immune/inflammatory responses, have been detected in the substantia nigra, serum, and olfactory neurons of Parkinson's disease (PD) patients. Of note, emerging evidence suggests that gut alterations, including dysbiosis and enteric inflammation, play a role in PD via the gut‐brain axis.
Objectives
Our goal was to investigate the expression of PK2 in colonic biopsies of PD patients.
Methods
Mucosal biopsies from the descending colon were obtained in 11 PD patients and five asymptomatic subjects. Biopsy samples were processed for PK2 immunofluorescence and western blot.
Results
We revealed an increased PK2 expression in colonic mucosa from PD patients in the early stages compared to controls. In addition, we found that PK2 was expressed by activated enteric glial cells and macrophages.
Conclusions
PK2 is highly expressed within neurogenic/inflammatory cells of colonic mucosa from early PD patients, suggesting a potential role of PK2 in gut inflammation, especially in the early stages of PD. © 2024 International Parkinson and Movement Disorder Society.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Neurology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
- Department of Neurology, the Marlene and Paolo Fresco Institute for Parkinson's Disease and Movement Disorders, New York University Langone Health, New York, New York, USA.
- Gastrointestinal Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
- Unit of Histology and Embryology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
- Neurology Unit, Department of Medical Specialties, AOUP, Pisa, Italy.
- Anatomia Patologica 2, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
ORCID-Profile: Gabriele Bellini, Lorenzo Fontanelli
Zitieren
APA
Bellini, G., Rettura, F., Palermo, G., Ippolito, C., Segnani, C., Pierucci, C., Fontanelli, L., Frosini, D., Nardini, V., Lambiase, C., Bernardini, N., Pellegrini, C., & Ceravolo, R. (2024). Prokineticin‐2 Is Highly Expressed in Colonic Mucosa of Early Parkinson's Disease Patients. Movement Disorders. https://doi.org/10.1002/mds.29937
Vancouver
Bellini G, Rettura F, Palermo G, Ippolito C, Segnani C, Pierucci C, et al. Prokineticin‐2 Is Highly Expressed in Colonic Mucosa of Early Parkinson's Disease Patients. Movement Disorders. 2024. doi:10.1002/mds.29937
BibTeX
@article{Bellini2024,
author = {Bellini, Gabriele and Rettura, Francesco and Palermo, Giovanni and Ippolito, Chiara and Segnani, Cristina and Pierucci, Clarissa and Fontanelli, Lorenzo and Frosini, Daniela and Nardini, Vincenzo and Lambiase, Christian and Bernardini, Nunzia and Pellegrini, Carolina and Ceravolo, Roberto},
title = {Prokineticin‐2 Is Highly Expressed in Colonic Mucosa of Early Parkinson's Disease Patients},
journal = {Movement Disorders},
year = {2024},
doi = {10.1002/mds.29937}
}
EUVIMED